27/07/2022
🗣 Today we introduce the latest addition to the Omnigen team, Kim Lensing, intern within our project ‘ISOLATE’ (DIagnoStic tOol Liver cAncer TreatmEnt).
"Hi! My name is Kim!
I am 23 years old, and I am a Master's student in Bioinformatics at Wageningen University & Research. As the last part of my Master's, I will do my internship at Omnigen.
In the upcoming months, I will be working on the ISOLATE project, where I will look for genetic markers that can predict liver cancer patients’ response to Sorafenib.
This could potentially lead to the development of a diagnostic tool that is able to distinguish responders from non-responders of treatment with Sorafenib among liver cancer patients.
I am excited about this opportunity, to do my internship at Omnigen, and I am sure I will learn a lot of new skills from Omnigen’s team!"
Good luck, Kim! 💪
✅ This project in which we collaborate with Levels Diagnostics has been granted the MIT R&D collaboration grant by Provincie Zuid-Holland.